Clinical Efficacy, Equivalence Concerns Hinder Embol-X Aortic Filter Review
This article was originally published in The Gray Sheet
Executive Summary
The difficulty of reconciling PMA clinical trial results with a 510(k) submission may hamper Embol-X, Inc.'s chances of achieving FDA clearance for its Embol-X aortic filter